Recursion Pharmaceuticals Inc (RXRX)
9.51
-0.50
(-5.00%)
USD |
NASDAQ |
May 16, 16:00
9.50
-0.01
(-0.11%)
Pre-Market: 09:12
Recursion Pharmaceuticals Accounts Payable (Quarterly): 5.115M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.115M |
| December 31, 2023 | 3.953M |
| September 30, 2023 | 4.265M |
| June 30, 2023 | 2.086M |
| March 31, 2023 | 4.247M |
| December 31, 2022 | 4.586M |
| September 30, 2022 | 3.89M |
| Date | Value |
|---|---|
| June 30, 2022 | 3.176M |
| March 31, 2022 | 4.162M |
| December 31, 2021 | 2.819M |
| September 30, 2021 | 6.326M |
| June 30, 2021 | 3.196M |
| March 31, 2021 | 3.125M |
| December 31, 2020 | 1.074M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.074M
Minimum
Dec 2020
6.326M
Maximum
Sep 2021
3.716M
Average
3.922M
Median
Accounts Payable (Quarterly) Benchmarks
| Eli Lilly and Co | 2.474B |
| Absci Corp | 1.653M |
| Palatin Technologies Inc | 1.594M |
| Oragenics Inc | 1.245M |
| Actinium Pharmaceuticals Inc | -- |